Prospective Quality of Life Study in Pituitary Surgery
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | September 26, 2018 | ||
首次发布日期e ICMJE | October 3, 2018 | ||
最后更新发布日期 | October 3, 2018 | ||
预计研究开始日期 ICMJE | October 2018 | ||
预计主要完成日期 | October 2020 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
SNOT-22 survey scores for pre-op/initial visit[ Time Frame: Survey results will be collected during the pre-op/initial 1 day visit ] Patient responses to the SNOT-22 will be collected and calculated. SNOT-22 survey scores for 2-week or 4-week follow-up visit[ Time Frame: 2-weeks or 4-weeks after surgery (based on group) ] Patient responses to the SNOT-22 will be collected and calculated. SNOT-22 survey scores for 8-week follow-up visit[ Time Frame: 8-weeks post-op ] Patient responses to the SNOT-22 will be collected and calculated. SNOT-22 survey scores for 3-month contact[ Time Frame: 3-month contact ] Patient responses to the SNOT-22 will be collected and calculated. SNOT-22 survey scores for 6-month follow-up visit[ Time Frame: 6-month post-op ] Patient responses to the SNOT-22 will be collected and calculated. Anterior Skull Base QOL survey scores for pre-op/initial visit[ Time Frame: collected during the pre-op/initial 1 day visit ] Patient responses to the Anterior Skull Base QOL will be collected and calculated. Anterior Skull Base QOL survey scores for 2-week or 4-week follow-up visit[ Time Frame: 2-weeks or 4-weeks after surgery (based on group) ] Patient responses to the Anterior Skull Base QOL will be collected and calculated. Anterior Skull Base QOL survey scores for 8-week follow-up visit[ Time Frame: 8-weeks post-op ] Patient responses to the Anterior Skull Base QOL will be collected and calculated. Anterior Skull Base QOL survey scores for 3-month contact[ Time Frame: 3-month contact ] Patient responses to the Anterior Skull Base QOL will be collected and calculated. Anterior Skull Base QOL survey scores for 6-month follow-up visit[ Time Frame: 6-month post-op ] Patient responses to the Anterior Skull Base QOL will be collected and calculated. Pain Catastrophizing Scale (PCS) response for pre-op/initial visit[ Time Frame: collected during the pre-op/initial 1 day visit ] Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated. Pain Catastrophizing Scale (PCS) response for 2-week or 4-week follow-up visit[ Time Frame: 2-weeks or 4-weeks after surgery (based on group) ] Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated. Pain Catastrophizing Scale (PCS) response for 8-week follow-up visit[ Time Frame: 8-weeks post-op ] Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated. Pain Catastrophizing Scale (PCS) response for 3-month contact[ Time Frame: 3-month contact ] Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated. Pain Catastrophizing Scale (PCS) response for 6-month follow-up visit[ Time Frame: 6-month post-op ] Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated. Questionnaire of Olfactory Disorders survey scores for pre-op/initial visit[ Time Frame: collected during the pre-op/initial 1 day visit ] Patient responses to the Pain Catastrophizing Scale (PCS) will be collected and calculated. Questionnaire of Olfactory Disorders survey scores for 2-week or 4-week follow-up visit[ Time Frame: 2-weeks or 4-weeks after surgery (based on group) ] Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated. Questionnaire of Olfactory Disorders survey scores for 8-week follow-up visit[ Time Frame: 8-weeks post-op ] Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated. Questionnaire of Olfactory Disorders survey scores for 3-month contact[ Time Frame: 3-month contact ] Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated. Questionnaire of Olfactory Disorders survey scores for 6-month follow-up visit[ Time Frame: 6-month post-op ] Patient responses to the Questionnaire of Olfactory Disorders will be collected and calculated. Skull Based Inventory scores for pre-op/initial visit[ Time Frame: collected during the pre-op/initial 1 day visit ] Patient responses to the Skull Based Inventory will be collected and calculated. Skull Based Inventory scores for 2-week or 4-week follow-up visit[ Time Frame: 2-weeks or 4-weeks after surgery (based on group) ] Patient responses to the Skull Based Inventory will be collected and calculated. Skull Based Inventory scores for 8-week follow-up visit[ Time Frame: 8-weeks post-op ] Patient responses to the Skull Based Inventory will be collected and calculated. Skull Based Inventory scores for 3-month contact[ Time Frame: 3-month contact ] Patient responses to the Skull Based Inventory will be collected and calculated. Skull Based Inventory scores for 6-month follow-up visit[ Time Frame: 6-month post-op ] Patient responses to the Skull Based Inventory will be collected and calculated. Quality of Recover (QOR 40) survey scores for pre-op/initial visit[ Time Frame: collected during the pre-op/initial 1 day visit ] Patient responses to the Quality of Recover (QOR 40) will be collected and calculated. Quality of Recover (QOR 40) survey scores for 2-week or 4-week follow-up visit[ Time Frame: 2-weeks or 4-weeks after surgery (based on group) ] Patient responses to the Quality of Recover (QOR 40) will be collected and calculated. Quality of Recover (QOR 40) survey scores for 8-week follow-up visit[ Time Frame: 8-weeks post-op ] Patient responses to the Quality of Recover (QOR 40) will be collected and calculated. Quality of Recover (QOR 40) survey scores for 3-month contact[ Time Frame: 3-month contact ] Patient responses to the Quality of Recover (QOR 40) will be collected and calculated. Quality of Recover (QOR 40) survey scores for 6-month follow-up visit[ Time Frame: 6-month post-op ] Patient responses to the Quality of Recover (QOR 40) will be collected and calculated. |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Prospective Quality of Life Study in Pituitary Surgery | ||
正式标题 ICMJE | Prospective Quality of Life Study in Pituitary Surgery | ||
简要概况 | Post-operative assessment and debridement are key components in patient care for surgery patients. However, a standardized protocol for management after endoscopic skull base surgery is unavailable. In this study, investigators will observe the effect of various follow-up schedules on the patient's quality of life after surgery. Patients who received surgery for pituitary adenoma will be placed randomly in 1 of 3 groups (short-term = follow-up in 2 weeks and 8 weeks after surgery; intermediate = 4 weeks and 8 weeks; long-term = 8 weeks). At each visit, patients will be asked to complete a packet of surveys and questionnaires that provide metrics on their quality of life in addition to receiving standard patient care (post-operative assessment and nasal debridement). Researchers hope to find that a follow-up schedule that has patients visiting the clinic closer to their surgery date will increase the patient's quality of life after surgery. |
||
详细说明 | |||
研究类型 ICMJE | Observational | ||
研究阶段 | |||
研究设计 ICMJE | 分配: 干预模型: 干预模型描述: 盲法: Observational 盲法描述: 主要目的: |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Not yet recruiting | ||
预计入组 ICMJE |
165 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | October 2020 | ||
预计主要完成日期 | October 2020 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - Has surgery for pituitary adenoma at UVA after May 1st, 2018 - Has sellar and parasellar pathology - ≥ 18 years old - Can complete all parts of study in English Exclusion Criteria: - Extended approaches - Use of naso-septal flap during the current surgical procedure - Septoplasty - Prior history of Chronic Rhinosinusitis (CRS) - Prior history of sphenoidotomy - < 18 years old - Prisoner | ||
性别 |
|
||
年龄 | 最小年龄:18 Years ,最大年龄:N/A | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | |||
管理信息 | 数据检测委员会 | ||
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | Jose Mattos, MD,University of Virginia | ||
研究赞助商 ICMJE | University of Virginia | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | University of Virginia | ||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |